Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -3.34 |
| peg ratio | -0.03 |
| price to book ratio | 1.95 |
| price to sales ratio | 139.62 |
| enterprise value multiple | -3.53 |
| price fair value | 1.95 |
profitability ratios | |
|---|---|
| gross profit margin | 66.96% |
| operating profit margin | -4588.47% |
| pretax profit margin | -4166.96% |
| net profit margin | -4166.96% |
| return on assets | -45.25% |
| return on equity | -48.91% |
| return on capital employed | -54.74% |
liquidity ratio | |
|---|---|
| current ratio | 10.26 |
| quick ratio | 10.26 |
| cash ratio | 1.99 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 167.19 |
| days of payables outstanding | 1,572.76 |
| cash conversion cycle | -1,405.57 |
| receivables turnover | 2.18 |
| payables turnover | 0.23 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | 0.17 |
| long term debt to capitalization | 0.08 |
| total debt to capitalization | 0.15 |
| interest coverage | -88.44 |
| cash flow to debt ratio | -2.21 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.25 |
| cash per share | 6.66 |
| operating cash flow per share | -2.19 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -2.21 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -35.93 |
Frequently Asked Questions
Pliant Therapeutics, Inc. (PLRX) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pliant Therapeutics, Inc. (NASDAQ:PLRX)'s trailing twelve months ROE is -48.91%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pliant Therapeutics, Inc. (PLRX) currently has a ROA of -45.25%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PLRX reported a profit margin of -4166.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.26 in the most recent quarter. The quick ratio stood at 10.26, with a Debt/Eq ratio of 0.17.